Bevacizumab
- All
- News
-
Promising New Treatment Boosts Survival Rates In Pediatric Cancer
The approach targets neuroblastomas, a rare form of cancer which develops in nerve cells.
-
No Medicines, Surgeries Cancelled As Sri Lanka's Health System Falters
Rosanne White was first diagnosed with cancer eight years ago and lost a kidney. After the cancer returned five years ago, an oncologist in Sri Lanka's commercial capital Colombo started her on Bevacizumab last May, a treatment she was responding to.
-
Hetero Launches Colorectal Cancer Drug In India
Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'.
-
Triple therapy improves vision in AMD
Simultaneous treatment with three modalities may improve or stabilise the vision of patients with neovascular AMD.
-
Promising New Treatment Boosts Survival Rates In Pediatric Cancer
The approach targets neuroblastomas, a rare form of cancer which develops in nerve cells.
-
No Medicines, Surgeries Cancelled As Sri Lanka's Health System Falters
Rosanne White was first diagnosed with cancer eight years ago and lost a kidney. After the cancer returned five years ago, an oncologist in Sri Lanka's commercial capital Colombo started her on Bevacizumab last May, a treatment she was responding to.
-
Hetero Launches Colorectal Cancer Drug In India
Drug firm Hetero on Monday launched a biosimilar of 'Bevacizumab', used in treating metastatic colorectal cancer (mCRC), under the brand name 'CizumabTM'.
-
Triple therapy improves vision in AMD
Simultaneous treatment with three modalities may improve or stabilise the vision of patients with neovascular AMD.
